Time Posted:2024-11-07 16:01
On November 5th, the "Chronic Disease Public Welfare Supporting Rural Revitalization" initiative, jointly promoted by Health Gen and Lizhu Group, visited Sunan County, Gansu Province. A donation ceremony was held in the second-floor meeting room of the County Committee Party School. Sunan County leaders Chou Shengrong, Zhang Aixia, and Fang Yuepeng, representatives from some townships, relevant county-level units, county-level medical and health units, and volunteers from Health Gen and Lizhu Group attended the ceremony.
Time Posted:2024-10-31 15:30
Recently, Healthy Yuan Pharmaceutical Group announced the launch of a new small molecule glucocorticoid drug. This drug targets respiratory diseases such as COPD, bronchial asthma, and rhinitis, and can provide patients with a more effective treatment plan by activating specific receptor activity.
The "Top 100 Private Enterprises in Guangdong Province 2024" list has been released
Time Posted:2024-10-29 11:00
On October 29, the "Top 100 Private Enterprises in Guangdong Province 2024" list was officially released.
Time Posted:2024-10-17 09:20
In recent years, thanks to the positive guidance of regulatory policies, China's capital market has gradually matured. Especially after the promulgation and implementation of the new "Nine Articles" policy, the pace of high-quality development of the capital market has significantly accelerated. The new "Nine Articles" policy particularly highlights the key role of the shareholder return mechanism and strongly advocates that listed companies adopt measures such as cash dividends and share buybacks to enhance returns for investors. Against this backdrop, HealthGen (600380.SH) has actively implemented various methods such as cash dividends and share buybacks to share the fruitful results of the company's development with its shareholders. Its series of high-frequency measures in the area of shareholder returns in recent years are particularly noteworthy.
Time Posted:2024-10-13 11:10
Recently, the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") announced the results of its 2023-2024 information disclosure evaluation for A-share listed companies on the main board. LiZhu Group was awarded an A rating (the highest), marking the fifth consecutive year the company has received this recognition. This is a testament to the SZSE's high regard for the company's information disclosure quality, investor relations, and sustainable development efforts.
For four consecutive years! Healthy Yuan has once again been awarded the Shanghai Stock Exchange's
Time Posted:2024-10-12 18:05
Recently, the Shanghai Stock Exchange (hereinafter referred to as the SSE) released the "Evaluation Results of Information Disclosure Work of Shanghai Main Board Listed Companies in 2023-2024". HealthGen (600380), with its solid operating performance, standardized corporate operation, high-quality information disclosure, and good investor relations management, once again received the highest rating of "A" (Excellent) in the SSE's 2023-2024 information disclosure work assessment. This is the fourth consecutive year the company has received this honor.
Time Posted:2024-09-23 12:45
In recent years, with the continuous advancement of the Internet wave, the digital transformation of health services has become almost a "must-answer question" for the development of pharmaceutical companies.
【Major News】Top 100 Chinese Pharmaceutical Companies of 2023 Released!
Time Posted:2024-09-07 17:00
The 2024 (41st) National Pharmaceutical Industry Information Annual Conference and the 2023 Top 100 Chinese Pharmaceutical Industry List Release Ceremony, hosted by the China Pharmaceutical Industry Information Center, guided by the China Pharmaceutical Industry Research General Institute, and undertaken by the Sichuan Provincial Department of Economy and Information Technology, opened in Chengdu on September 7.